Not all people with CLL have to have therapy. Despite all latest advances, the iwCLL continue to endorses watchful observation for sufferers with asymptomatic illness.86 This recommendation relies on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).C